"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 7 | 7 |
1996 | 0 | 7 | 7 |
1997 | 0 | 10 | 10 |
1998 | 0 | 13 | 13 |
1999 | 0 | 9 | 9 |
2000 | 2 | 9 | 11 |
2001 | 2 | 15 | 17 |
2002 | 2 | 12 | 14 |
2003 | 1 | 32 | 33 |
2004 | 1 | 21 | 22 |
2005 | 2 | 33 | 35 |
2006 | 1 | 30 | 31 |
2007 | 1 | 38 | 39 |
2008 | 2 | 47 | 49 |
2009 | 3 | 42 | 45 |
2010 | 0 | 46 | 46 |
2011 | 2 | 50 | 52 |
2012 | 3 | 49 | 52 |
2013 | 3 | 51 | 54 |
2014 | 2 | 48 | 50 |
2015 | 3 | 66 | 69 |
2016 | 4 | 54 | 58 |
2017 | 5 | 66 | 71 |
2018 | 1 | 52 | 53 |
2019 | 5 | 62 | 67 |
2020 | 3 | 41 | 44 |
2021 | 3 | 36 | 39 |
2022 | 0 | 20 | 20 |
2023 | 3 | 15 | 18 |
2024 | 7 | 14 | 21 |
2025 | 2 | 17 | 19 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Frequent Missed Opportunities for Earlier Diagnosis of Advanced-Stage Colorectal or Lung Cancer. JAMA Intern Med. 2025 Sep 01; 185(9):1102-1108.
-
Radiologist's Guide to the Ninth Edition TNM Staging System for Quantitative and Qualitative Assessment of Pleural Mesothelioma. Radiology. 2025 Sep; 316(3):e250531.
-
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study. Oral Oncol. 2025 Aug; 167:107446.
-
Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study. Gynecol Oncol. 2025 Aug; 199:1-9.
-
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. Mol Cancer. 2025 Jun 11; 24(1):175.
-
National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: The impact of the KATHERINE trial. Breast Cancer Res Treat. 2025 Aug; 212(3):531-543.
-
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer. Clin Cancer Res. 2025 May 01; 31(9):1615-1624.
-
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial. Breast Cancer Res Treat. 2025 Jul; 212(1):57-69.
-
Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. 2025 Apr 03; 46(2).
-
Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation. Front Immunol. 2025; 16:1529707.